NCT00020735View on ClinicalTrials.gov

Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

January 31, 2005

Study Completion Date

June 30, 2009

Conditions
Prostate Cancer
Interventions
DRUG

toremifene

PROCEDURE

conventional surgery

PROCEDURE

neoadjuvant therapy

Trial Locations (1)

15232

Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Joel Nelson, MD

OTHER

NCT00020735 - Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer | Biotech Hunter | Biotech Hunter